Hofseth Biocare ASA (0Q6H) Stock Statistics & Valuation Metrics

Hofseth Biocare ASA has a market cap or net worth of $937.26M. The enterprise value is ―.

Hofseth Biocare ASA has 395,081,020 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hofseth Biocare ASA’s return on equity (ROE) is -1.99 and return on invested capital (ROIC) is -65.46%.

The current PE Ratio of Hofseth Biocare ASA is -5.66. Hofseth Biocare ASA’s PEG ratio is -0.74.

In the last 12 months, Hofseth Biocare ASA had revenue of 257.42M and earned -123.41M in profits. Earnings per share was -0.30.

In the last 12 months, operating cash flow was -47.07M and capital expenditures -3.46M, giving a free cash flow of -51.15M billion.

Hofseth Biocare ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Hofseth Biocare ASA upcoming earnings date is Aug 22, 2025, TBA Not Confirmed.

Hofseth Biocare ASA as a current ratio of 0.67, with Debt / Equity ratio of 0.00%

In the past 12 months, Hofseth Biocare ASA has paid 0.00 in taxes.

Hofseth Biocare ASA EV to EBITDA ratio is -9.90, with an EV/FCF ratio of -48.47.

Hofseth Biocare ASA has $25.58M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -$25.58M billion.

Gross margin is 26.28%, with operating margin of -43.98%, and net profit margin of -47.94%.

The average price target for Hofseth Biocare ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―